Application of nanofat for treatment of traumatic faecal incontinence after sphincteroplasty – A pilot study
Authorized Users Only
2022
Authors
Barišić, GoranAnđelkov, Katarina
Rosić, Jovana

Miladinov, Marko
Kotur-Stevuljević, Jelena

Dinić, Tanja
Jelenković, Jelenko
Krivokapić, Zoran
Article (Published version)

Metadata
Show full item recordAbstract
Aim: The aim of this study was to investigate whether the application of nanofat contain-ing stem cells improves continence in women who had previously undergone anal sphinc-teroplasty with unsatisfactory long-term outcomes.Method: This prospective pilot study included nine women with various degrees of anal incontinence who had previously undergone anal sphincteroplasty due to obstetric trauma. In all patients, the Wexner Incontinence Score (WS) and Faecal Incontinence Quality of Life Score (FIQLS), as well as anal manometry and endoanal ultrasound meas-urements, were performed before the procedure and during follow-up. In all patients, liposuction was performed and 50 ml of raw lipoaspirate was obtained and processed using a NanoFat Kit device. Approximately 20 ml of the mechanically emulsified and fil-trated fat was obtained and the anal sphincter complex was infiltrated with it. Patient fol-low-up was conducted in person or via teleph...one 6 and 12 months after the procedure.Results: The squeeze pressure was significantly increased 6 months after the proce-dure (p= 0.01). The external anal sphincter measured at the 12 o'clock position was sig-nificantly thicker (p= 0.04). A significant decrease in the WS was observed both 6 and 12 months after the procedure compared with baseline values (p< 0.05 for both).Conclusion: This study is the first to show that the application of nanofat as an inject-able product improves continence in patients with unsatisfactory results after sphinc-teroplasty, suggesting it to be a promising and effective therapeutic tool. The procedure is safe and can be easily performed as an ambulatory procedure.
Keywords:
adipose-derived stromal cells / faecal incontinence / liposuction / nanofat / regenerative cell-based medicine / sphincteroplastySource:
Colorectal Disease, 2022, 24, 9, 1054-1062Publisher:
- John Wiley and Sons Inc
DOI: 10.1111/codi.16148
ISSN: 1462-8910
WoS: 000789539400001
Scopus: 2-s2.0-85128678915
Collections
Institution/Community
PharmacyTY - JOUR AU - Barišić, Goran AU - Anđelkov, Katarina AU - Rosić, Jovana AU - Miladinov, Marko AU - Kotur-Stevuljević, Jelena AU - Dinić, Tanja AU - Jelenković, Jelenko AU - Krivokapić, Zoran PY - 2022 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4092 AB - Aim: The aim of this study was to investigate whether the application of nanofat contain-ing stem cells improves continence in women who had previously undergone anal sphinc-teroplasty with unsatisfactory long-term outcomes.Method: This prospective pilot study included nine women with various degrees of anal incontinence who had previously undergone anal sphincteroplasty due to obstetric trauma. In all patients, the Wexner Incontinence Score (WS) and Faecal Incontinence Quality of Life Score (FIQLS), as well as anal manometry and endoanal ultrasound meas-urements, were performed before the procedure and during follow-up. In all patients, liposuction was performed and 50 ml of raw lipoaspirate was obtained and processed using a NanoFat Kit device. Approximately 20 ml of the mechanically emulsified and fil-trated fat was obtained and the anal sphincter complex was infiltrated with it. Patient fol-low-up was conducted in person or via telephone 6 and 12 months after the procedure.Results: The squeeze pressure was significantly increased 6 months after the proce-dure (p= 0.01). The external anal sphincter measured at the 12 o'clock position was sig-nificantly thicker (p= 0.04). A significant decrease in the WS was observed both 6 and 12 months after the procedure compared with baseline values (p< 0.05 for both).Conclusion: This study is the first to show that the application of nanofat as an inject-able product improves continence in patients with unsatisfactory results after sphinc-teroplasty, suggesting it to be a promising and effective therapeutic tool. The procedure is safe and can be easily performed as an ambulatory procedure. PB - John Wiley and Sons Inc T2 - Colorectal Disease T1 - Application of nanofat for treatment of traumatic faecal incontinence after sphincteroplasty – A pilot study VL - 24 IS - 9 SP - 1054 EP - 1062 DO - 10.1111/codi.16148 ER -
@article{ author = "Barišić, Goran and Anđelkov, Katarina and Rosić, Jovana and Miladinov, Marko and Kotur-Stevuljević, Jelena and Dinić, Tanja and Jelenković, Jelenko and Krivokapić, Zoran", year = "2022", abstract = "Aim: The aim of this study was to investigate whether the application of nanofat contain-ing stem cells improves continence in women who had previously undergone anal sphinc-teroplasty with unsatisfactory long-term outcomes.Method: This prospective pilot study included nine women with various degrees of anal incontinence who had previously undergone anal sphincteroplasty due to obstetric trauma. In all patients, the Wexner Incontinence Score (WS) and Faecal Incontinence Quality of Life Score (FIQLS), as well as anal manometry and endoanal ultrasound meas-urements, were performed before the procedure and during follow-up. In all patients, liposuction was performed and 50 ml of raw lipoaspirate was obtained and processed using a NanoFat Kit device. Approximately 20 ml of the mechanically emulsified and fil-trated fat was obtained and the anal sphincter complex was infiltrated with it. Patient fol-low-up was conducted in person or via telephone 6 and 12 months after the procedure.Results: The squeeze pressure was significantly increased 6 months after the proce-dure (p= 0.01). The external anal sphincter measured at the 12 o'clock position was sig-nificantly thicker (p= 0.04). A significant decrease in the WS was observed both 6 and 12 months after the procedure compared with baseline values (p< 0.05 for both).Conclusion: This study is the first to show that the application of nanofat as an inject-able product improves continence in patients with unsatisfactory results after sphinc-teroplasty, suggesting it to be a promising and effective therapeutic tool. The procedure is safe and can be easily performed as an ambulatory procedure.", publisher = "John Wiley and Sons Inc", journal = "Colorectal Disease", title = "Application of nanofat for treatment of traumatic faecal incontinence after sphincteroplasty – A pilot study", volume = "24", number = "9", pages = "1054-1062", doi = "10.1111/codi.16148" }
Barišić, G., Anđelkov, K., Rosić, J., Miladinov, M., Kotur-Stevuljević, J., Dinić, T., Jelenković, J.,& Krivokapić, Z.. (2022). Application of nanofat for treatment of traumatic faecal incontinence after sphincteroplasty – A pilot study. in Colorectal Disease John Wiley and Sons Inc., 24(9), 1054-1062. https://doi.org/10.1111/codi.16148
Barišić G, Anđelkov K, Rosić J, Miladinov M, Kotur-Stevuljević J, Dinić T, Jelenković J, Krivokapić Z. Application of nanofat for treatment of traumatic faecal incontinence after sphincteroplasty – A pilot study. in Colorectal Disease. 2022;24(9):1054-1062. doi:10.1111/codi.16148 .
Barišić, Goran, Anđelkov, Katarina, Rosić, Jovana, Miladinov, Marko, Kotur-Stevuljević, Jelena, Dinić, Tanja, Jelenković, Jelenko, Krivokapić, Zoran, "Application of nanofat for treatment of traumatic faecal incontinence after sphincteroplasty – A pilot study" in Colorectal Disease, 24, no. 9 (2022):1054-1062, https://doi.org/10.1111/codi.16148 . .